N/A Completed N=25

Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy

Vitrectomy

Source: ClinicalTrials.gov NCT01319318 ↗

Enrolled (actual)

Serious AEs

4.0%

Results posted

Jul 2013

Primary outcomePrimary: Percentage of Participants With Vitreous Cell Count of 0 — 88.0 Percentage of participants

Summary

This study will evaluate the degree of post-operative ocular inflammation in patients who are undergoing a pars plana vitrectomy.

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Participants With Vitreous Cell Count of 0	88.0	—

Eligibility Criteria

Inclusion Criteria

Require pars plana vitrectomy in at least 1 eye
Best corrected visual acuity in the study eye between 20/400 and 20/40

Exclusion Criteria

Use of any NSAIDs (topical or systemic) within 14 days
Use of topical or systemic steroids within 30 days
Active eye infection in either eye
Any eye surgery within 6 months
Prior pars plana vitrectomy, YAG capsulotomy or uveitis

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01319318). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.